PODCAST

CME

ReachMD

science & medicine medicine

All Episodes

00:00:00

Advancing Multidisciplinary Care in TGCT: Integrating...

CME ·

2025/02/28

Host: William D. Tap, MD Host: John Healey, MD In this activity, a medical oncologist and orthopedic surgeon discuss evidence-based surgical and systemic therapy approaches for the treatment of tenosynovial giant cell tumors (TGCT). Topics include differentiating TGCT by presentation; surgical candidacy, approaches, and limitations; systemic treatment options with CSF1R inhibitors; and considerations for treatment selection with surgical, nonsurgical, or combination interventions

00:00:00

Trade off: Ischemic/Thrombotic vs Bleeding

CME ·

2025/02/14

Host: Renato D. Lopes, MD, MHS, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning

00:00:00

How Do We Translate Real-World VTE Data Into Everyday...

CME ·

2025/02/14

Guest: Alexander T. Cohen, MD, MBBS The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning

00:00:00

Elevating Care for Patients With Severe Renal Disease...

CME ·

2025/02/14

Host: Silke R. Brix, MD, MRCP, SCPR Guest: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

How Do We Translate Real-World AF Data Into Everyday...

CME ·

2025/02/14

Host: Renato D. Lopes, MD, MHS, PhD Guest: Valeria Caso, MD, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our

00:00:00

Optimizing AAV Outcomes: Maintenance Therapies

CME ·

2025/02/14

Host: Bernhard Hellmich, MD Guest: Silke R. Brix, MD, MRCP, SCPR Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Don't Miss It! Rapid & Accurate AAV Diagnosis

CME ·

2025/02/14

Guest: Silke R. Brix, MD, MRCP, SCPR Host: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Implications Associated With Integrating Both...

CME ·

2025/02/14

00:00:00

Patient Case Study: Obesity and VTE

CME ·

2025/02/14

Host: Renato D. Lopes, MD, MHS, PhD Guest: Alexander T. Cohen, MD, MBBS The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our

00:00:00

Implications Associated With Integrating Both...

CME ·

2025/02/14

Guest: Valeria Caso, MD, PhD The effective management of atrial fibrillation (AF) remains a high priority for many clinicians worldwide because a significant number of people globally who are living with AF are at risk of developing venous thromboembolism (VTE). This makes our understanding and implementation of new findings and clinical trial outcomes that much more important as we develop effective, personalized treatment plans for our patients. Tune in to our micro learning course

00:00:00

Setting the Stage of Real-World Data vs RCT

CME ·

2025/02/14

00:00:00

Patient Case Study: Obesity

CME ·

2025/02/14

00:00:00

Implementing the SOC Induction Therapies in AAV

CME ·

2025/02/14

Host: Silke R. Brix, MD, MRCP, SCPR Guest: Bernhard Hellmich, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Tailoring Treatment for Optimal Outcomes in Patients...

CME ·

2025/02/14

Host: Bernhard Hellmich, MD Guest: Andreas Kronbichler, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Patient Case Study: Cancer-Associated Thrombosis

CME ·

2025/02/14

00:00:00

Managing Patients With AAV in the Rheumatology Clinic

CME ·

2025/02/14

Host: Andreas Kronbichler, MD Guest: Bernhard Hellmich, MD Blood vessel inflammation that occurs with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis – or AAV – often results in damage that can lead to multi-organ involvement. This makes early diagnosis of this rare, autoimmune disease important for developing an effective treatment plan and personalized treatment selection a key success factor in the optimization of patient care.

00:00:00

Patient Case Study: Elderly

CME ·

2025/02/14

00:00:00

Beyond the Broadcast: Expert Insights on SGLT2...

CME ·

2025/02/04

Host: Melissa Magwire, RN, MSN, CDE Guest: Matthew Bullington, PharmD Guest: Dawn M. Denicola, FNP-C Guest: Keith Miller, MD Are you up to date on the plethora of benefits patients may receive from SGLT2 inhibitors? Learn from a multidisciplinary faculty panel as they use patient case vignettes to review emerging evidence and evolving treatment guidelines related to cardio-renal-metabolic comorbidities such as type 2 diabetes, heart failure, chronic kidney disease, and

00:00:00

Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT):...

CME ·

2025/01/31

Guest: Karin J. Blakemore, MD Guest: Emilie L. Vander Haar Fetal and neonatal alloimmune thrombocytopenia (FNAIT) can lead to substantial medical challenges for the mother, fetus, and neonate. Diagnosis is often difficult without low platelet counts or frank bleeding. But a mother’s risk for FNAIT can be assessed, and existing and newly emerging therapies can act as preventive measures and improve fetus/neonate outcomes. Join Drs. Karin Blakemore and Emilie Vander Haar as they

00:00:00

Classification/Suspecting a Diagnosis of FNAIT/NAIT

CME ·

2025/01/31

316 results

CME

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe